Similarly, the results in subtotal analysis stratified by WHO grade of glioma showed that five studies of WHO IV glioma exhibited a significant association between increased expression of CD133 and poor OS (HR 1.46; 95 % CI, 1.19–1.80, p = 0.000 I2 = 0.00). This evidence concerns the gene PROM1 and central nervous system cancer.